Day 2, Wednesday, March 19th, 2025 - EST/EDT (Eastern Daylight, GMT-4)
Provide a comprehensive understanding of the existing regulatory landscape governing patient support services and hub models, including FDA guidelines, compliance standards and industry best practices
Gain valuable insights into the latest enforcement actions and the ramifications of recent cases
Uncover the top areas of focus for 2025
- Evan Panich - Assistant United States Attorney, U.S. Attorney’s Office, District of Massachusetts
After hearing from Enforcement directly, take this opportunity for a broader level set. Gain insight into current policies and pending changes to understand how the patient services industry will continue to be affected and what your organization can do to prepare and adapt accordingly.
- Jennie Sakimura - Senior Director, Patient Services & Specialty Pharmacy Programs, Sanofi
- Mallory O’Connor - Executive Director, Public Policy, Mallinckrodt
As patient adherence continues to evolve alongside the rest of the patient services industry, take look at the new adherence design stands and benchmarking.
Understand the importance of tailoring adherence programs to individual patient needs, preferences and conditions
Learn how to use patient reported outcomes to measure adherence and effectiveness to inform program adjustments
Uncover digital health tools, including AI, ML and beyond, to improve adherence and use in combination with live support
- Nareda Mills - President, Patient Solutions, Inizio Engage
**Please contact karen.hanover@informa.com if you would like to attend**
Though the Inflation Reduction Act is well under way, stakeholders must remain agile. During this session, understand the impact that the IRA has had thus far on patient services and how it is going to continue to evolve.
Receive an update on how the IRA is going and the specific changes that organizations are seeing
Benchmark with peers to understand how their patient services have shifted as a result
Understand the updated Medicare out-of-pocket cap and what it means for manufacturers as they think about affordability
- Joel White - President, Horizon Government Affairs
Conversations are a source of insight that can be a powerful unifying force leveraged to align on strategy, problem-solving, intelligence and service. AI built specifically for healthcare is creating algorithms that understand the context of the healthcare experience at every stage of the brand lifecycle, delivering a compounding value for both business and patient outcomes.
Discuss how conversational data provides value at every stage of the brand lifecycle, from launch, steady state, competition and to patent expiration
Learn common friction points in the patient journey, such as delays in access, abandonment and how pharmacies are navigating and generating solutions by listening at scale
Identify actionable ways artificial intelligence can help you achieve the outcomes for your business and for the patients you serve
- Amy Brown - CEO and Founder, Authentix
This session will dive into the critical role of gross-to-net within hub programs. Gain a comprehensive understanding of the factors influencing GTN, strategies to maintain and improve GTN without compromising growth and best practices to ensure the long-term sustainability of hub programs.
Analyze the impact of various GTN components such as patient assistance programs, copay cards and rebates on overall profitability
Develop effective strategies to optimize GTN while balancing patient access and commercial objectives
Leverage data and analytics to identify opportunities for GTN improvement
Address the challenges and opportunities presented by evolving market dynamics and regulatory changes
While integrated specialty pharmacy services are not new, they are becoming a more popular model of care as the number of complex care treatments on the market continues to increase.
Learn more about the technologies and systems that medically integrated specialty pharmacies (MIPs) use to improve efficiency and patient outcome
Uncover the benefits MIPs provide for healthcare practices, patients and costs by allowing for real-time access to patient medical records, labs and notes and easier access to prescribing clinicians
Learn how MIPs allow for more holistic and focused patient support
- Karen Thomas - Associate Director, Specialty and Infusion Pharmacies and Clinical Assistant Professor, University of Illinois Chicago
With retail pharmacy, specialty pharmacies, specialty distributors and more, there is a whole distribution model playbook that manufacturers must consider when launching a new product.
Uncover the challenges in retail pharmacy, including over saturation
Discuss alternative options to retail pharmacies and their respective considerations
Understand the benefit of patient services working with trade and distribution to maximize value and minimize cost
- Meghan Szczech, MBA - Executive Director, Patient Services and Trade, SK Life Science
- Chris Boneham - Vice President, Market Access US, Y-mAbs Therapeutics, Inc